Jane Joy Thomas
Impact in
- Dermatology top 5%
- Cutaneous lymphoproliferative disorders research
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Parathyroid Disorders and Treatments 3
- Genetics 5
- Virus-based gene therapy research 3
- Genetic Syndromes and Imprinting 2
- Co-authors
- Chandra P. Sharma (3 shared papers)M.R. Rekha (3 shared papers)Rostislav Novak (1 shared paper)Walter Birchmeier (1 shared paper)Ma. Xenia G. Ilagan (1 shared paper)Raphael Kopan (1 shared paper)Julie S. Trausch‐Azar (1 shared paper)Julian Heuberger (1 shared paper)
- Journals
- Cell Reports (2 papers)Blood (2 papers)International Journal of Pharmaceutics (1 paper)Kidney International (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesIndiaGermany
In The Last Decade
Jane Joy Thomas
10 papers receiving 376 citations
Peers
Comparison fields: 5 of 62
- Dermatology 107
- Pathology and Forensic Medicine 87
- Immunology 66
- Oncology 69
- Biomaterials 36
Countries citing papers authored by Jane Joy Thomas
This map shows the geographic impact of Jane Joy Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Joy Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Joy Thomas more than expected).
Fields of papers citing papers by Jane Joy Thomas
This network shows the impact of papers produced by Jane Joy Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Joy Thomas. The network helps show where Jane Joy Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Jane Joy Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 77 | |
| 2 | 2021 | 73 | |
| 3 | 2016 | 50 | |
| 4 | 2021 | 41 | |
| 5 | 2010 | 41 | |
| 6 | 2011 | 37 | |
| 7 | 2010 | 32 | |
| 8 | 2023 | 22 | |
| 9 | 2023 | 12 | |
| 10 | 2026 | 1 |
About Jane Joy Thomas
Jane Joy Thomas is a scholar working on Nephrology, Genetics, Dermatology, Oncology and Pathology and Forensic Medicine, having authored 10 papers that have together received 386 indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (3 papers), Virus-based gene therapy research (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), RNA Interference and Gene Delivery (3 papers), Genetic Syndromes and Imprinting (2 papers), Lymphoma Diagnosis and Treatment (2 papers), T-cell and B-cell Immunology (2 papers) and Cutaneous lymphoproliferative disorders research (2 papers). The work is most often cited by research in Dermatology (107 citations), Pathology and Forensic Medicine (87 citations), Immunology (66 citations), Oncology (69 citations) and Biomaterials (36 citations). Jane Joy Thomas has collaborated with scholars based in United States, India and Germany. Frequent co-authors include Chandra P. Sharma, M.R. Rekha, Rostislav Novak, Walter Birchmeier, Ma. Xenia G. Ilagan, Raphael Kopan, Julie S. Trausch‐Azar, Julian Heuberger, Gunnar Dittmar and Amir Orian. Their work appears in journals such as Cell Reports, Blood, International Journal of Pharmaceutics, Kidney International and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.